Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: The RECOMB study

1. Ribera, E.
2. Larrousse, M.
3. Curran, A.
4. Negredo, E.
5. Clotet, B.
6. Estrada, V.
7. Sanz, J.
8. Berenguer, J.
9. Rubio, R.
10. Pulido, F.
11. Ferrer, P.
12. Alvarez, M.
13. Arterburn, S.
14. Martínez, E.